Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2010
09/10/2010WO2010101247A1 Cyclohexane derivative having npy y5 receptor antagonism
09/10/2010WO2010101246A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
09/10/2010WO2010101164A1 Pyridine derivative
09/10/2010WO2010100933A1 Anti-obesity agent and diabetes-ameliorating agent
09/10/2010WO2010100337A1 Novel prodrugs of metformin
09/10/2010WO2010100207A1 Pharmaceutical compositions of active pharmaceutical ingredient comprising sulphonylurea moiety with excellent dissolution properties
09/10/2010WO2010100060A2 Method for increasing endogenous plasmalogen levels in mammals
09/10/2010WO2010099938A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
09/10/2010WO2010099698A1 Salts of tetrahydroimidazo [1,5-a] pyrazine derivatives, preparation methods and pharmaceutical use thereof
09/10/2010WO2010071358A3 Method of preparing ezetimibe and intermediates used therein
09/10/2010WO2010064845A3 The pharmaceutical composition or the functional foods for the treatment or prevention of obesity comprising the extract from myristica fragrans houttuyn
09/10/2010WO2010054324A3 Methods for treating clinical conditions associated with lipoprotein lipase activity
09/10/2010WO2010052448A3 Fused pyrazine derivatives as kinase inhibitors
09/10/2010WO2009068531A3 Adamantyl o-glucuronide derivatives as inhibitors of dipeptidyl peptidase iv for the treatment of diabetes
09/10/2010CA2754446A1 Pyridine derivative
09/10/2010CA2754330A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
09/10/2010CA2754058A1 8-substituted quinolines and related analogs as sirtuin modulators
09/10/2010CA2753991A1 Secreted ap2 and methods of inhibiting same
09/10/2010CA2753862A1 Tetrahydro-imidazo[1,5-.alpha.]pyrazine derivatives salts, preparation methods and medicinal use thereof
09/10/2010CA2751227A1 Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
09/09/2010US20100228018 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/09/2010US20100227934 Therapeutic compounds and methods of use
09/09/2010US20100227901 Compounds for the treatment of metabolic disorders
09/09/2010US20100227888 Modulators of cftr
09/09/2010US20100227874 Reduction of oxidative stress damage during or after exercise
09/09/2010US20100227873 Nitrogen-containing heterocyclic compounds and methods of use thereof
09/09/2010US20100227860 Disalt inhibitors of il-12 production
09/09/2010US20100227859 Tricyclic compounds as matrix metalloproteinase inhibitors
09/09/2010US20100227857 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors
09/09/2010US20100227855 Helix 12 directed non-steroidal antiandrogens
09/09/2010US20100227848 Oxo bridged diazepan orexin receptor antagonists
09/09/2010US20100227847 Non-Anilinic Derivatives Of Isothiazol-3(2H)-one 1,1-Dioxides As Liver X Receptor Modulators
09/09/2010US20100227841 Patient populations and treatment methods
09/09/2010US20100227840 Use of 25-hydroxy vitamin d3 to improve male animal fertility
09/09/2010US20100227830 Use of escin
09/09/2010US20100227828 New synergistic phytochemical composition for the treatment of obesity
09/09/2010US20100227827 Method of increasing tryptophan and nicotinamide levels in vivo
09/09/2010US20100227817 Metabolic and cardioprotection by the myokine follistatin-like 1 polypeptide
09/09/2010US20100227814 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes
09/09/2010US20100227809 Combination treatment for metabolic disorders
09/09/2010US20100227805 Molecules and Methods of Using Same for Treating CCR5/CCR5 Ligands Associated Diseases
09/09/2010US20100227800 Triazole derivatives as kinase inhibitors
09/09/2010US20100227797 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives
09/09/2010US20100227796 Insulin Derivatives
09/09/2010US20100227795 Insulin formulations for rapid uptake
09/09/2010US20100227354 Autoimmune Conditions and NADPH Oxidase Defects
09/09/2010US20100227002 Antioxidant compositions comprising extracts of myrtle and rosemary
09/09/2010US20100226990 Method of Producing Porous Microparticles
09/09/2010US20100226985 Viscoelastic aqueous gels comprising microspheres
09/09/2010US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides
09/09/2010US20100226891 Surface expression vector for fusion protein of myo-2 peptide multimer and myostatin, and microorganism transformed by thereof
09/08/2010EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii
09/08/2010EP2226321A2 Process for producing thiazolidinediones and intermediates thereof
09/08/2010EP2226315A1 2-aminoquinazoline derivative
09/08/2010EP2226076A1 Plant Extract for the Prophylaxis and Treatment of Hyperglycemic Diseases
09/08/2010EP2226071A1 Composition for oral administration
09/08/2010EP2225261A1 Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
09/08/2010EP2225227A2 Compounds
09/08/2010EP2225223A2 Organic compounds
09/08/2010EP2224945A1 Methods of enhancing diabetes resolution
09/08/2010EP2224937A2 Composition for preventing and treating metabolic diseases comprising the extract of lysimachiae foenum-graeci herba
09/08/2010EP1773811B1 A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarbox amide hemisuccinate salt
09/08/2010EP1572230B1 Placental alkaline phosphatase to control diabetes
09/08/2010EP1521839B1 Methods of making viral particles having a modified cell binding activity and uses thereof
09/08/2010EP1478624B1 Chemical compounds
09/08/2010EP1412374B1 Novel pgc-1 isoforms and uses therefor
09/08/2010EP1399190B1 Pharmaceutical compositions comprising low-solubility and acid-sensitive drugs and neutralized acidic polymers
09/08/2010EP1388340B1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
09/08/2010EP1382336B1 Use of the abc expression promotor pioglitazone for the treatment of arteriosclerosis obliterans
09/08/2010EP1263759B1 Azaindoles
09/08/2010CN201572341U Compound amlodipine besylate atorvastatin calcium tablet
09/08/2010CN1965885B Application of total flavones of chickpea in preparation of medicament for treating diabetes
09/08/2010CN1960723B Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight
09/08/2010CN1960722B Use of furan alkyl for preparing an antidiabetic drug
09/08/2010CN1931260B Hyperlipemia treating oral liquid
09/08/2010CN1931254B Diabetes treating medicine
09/08/2010CN1777418B Composition for slimming
09/08/2010CN1732154B Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
09/08/2010CN1662224B Agent for producing a sensation of satiety and for weight loss
09/08/2010CN101827847A Purine derivatives as adenosine al receptor ligands
09/08/2010CN101827842A Oxadiazole derivatives as dgat inhibitors
09/08/2010CN101827840A Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators
09/08/2010CN101827832A Acetamide derivatives as glucokinase activators, their process and medicinal applications
09/08/2010CN101827826A 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof
09/08/2010CN101827820A Aminopyrazole amide derivative
09/08/2010CN101827807A Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt
09/08/2010CN101827600A Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
09/08/2010CN101824423A Fusion gene GAD-GLP-1 and culture method of diabetes diet therapy type cucumber
09/08/2010CN101824388A Yeast for dietary therapy of diabetes and construction method thereof
09/08/2010CN101824086A Preparation method of pramlintide
09/08/2010CN101824076A Micro-assisted solid-phase synthesis of analogue of MC-JJ0105 polypeptide isolated from Momordica charantia and application of the analogue
09/08/2010CN101824075A Micro-assisted solid-phase synthesis of analogue of MC-JJ0101 polypeptide isolated from Momordica charantia and application of the analogue
09/08/2010CN101824074A Micro-assisted solid-phase synthesis of analogue of MC-JJ0107 polypeptide isolated from Momordica charantia and application of the analogue
09/08/2010CN101824073A Micro-assisted solid-phase synthesis of analogue of MC-JJ0103 polypeptide isolated from Momordica charantia and application of the analogue
09/08/2010CN101824036A Salt of tetrahydroimidazo [1,5-a] pyrazine derivative, preparation method and pharmaceutical application thereof
09/08/2010CN101823956A Diisopropylamine fenofibrate, preparation method of same, medicinal composition and use of same
09/08/2010CN101822837A Medicine composition containing allisartan isoproxil salts
09/08/2010CN101822836A Medicine composition containing allisartan isoproxil
09/08/2010CN101822834A Remedy for diabetes
09/08/2010CN101822822A Drug composition of pramlintide and preparation method thereof
1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 1298